Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...

The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...

FDA officials have warned the American public to not eat, sell or serve cucumbers grown and distributed by two Florida ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...

The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years ...

Tracy Beth Høeg, MD, PhD, a sports medicine physician focused on ultramarathon runners who rose to prominence by challenging ...

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.